drugset / Trial / NCT01098071

Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)

NCT01098071

Phase 4 Completed 34 enrolled Organon and Co
NaSingle-groupOpen-labelTreatment

Summary

To document the short term \& long term effect of treatment with Nasonex (mometasone furoate nasal spray) in moderate to severe adenoids hypertrophy (which cause \> 50% obstruction of the posterior choanae).

Timeline

Start
2008-08-01
Primary completion
2009-09-01
Completion
2009-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 100 ug Intranasal

Indications